Company Filing History:
1 out of 410 
1 out of 32 
Years Active: 2025
Title: Innovations of James Daniel in Autoimmune Inflammation Treatment
Introduction
James Daniel is an accomplished inventor based in Newark, CA. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of treatments for autoimmune inflammation diseases. His innovative work has led to the creation of a patent that addresses critical health issues.
Latest Patents
James Daniel holds a patent for "Lipidated peptide inhibitors of interleukin-23 receptor." This invention relates to novel lipidated peptide inhibitors of the interleukin-23 receptor (IL-23R) or pharmaceutically acceptable salts, solvates, and/or other forms thereof. The corresponding pharmaceutical compositions, methods, and uses of the IL-23R inhibitors are aimed at treating autoimmune inflammation diseases and related disorders. He has 1 patent to his name.
Career Highlights
Throughout his career, James has worked with notable companies in the biotechnology sector. He has been associated with Janssen Biotech, Inc. and Protagonist Therapeutics, Inc., where he has contributed to various innovative projects and research initiatives.
Collaborations
(Section skipped due to space constraints.)
Conclusion
James Daniel's work in developing lipidated peptide inhibitors showcases his commitment to advancing medical treatments for autoimmune diseases. His innovative contributions are paving the way for new therapeutic options in the pharmaceutical industry.